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The SUMMIT ambulatory‑ICU primary
care model for medically and socially complex
patients in an urban federally qualified health
center: study design and rationale
Brian Chan1,2* , Samuel T. Edwards1,3, Meg Devoe1,2, Richard Gil1,2, Matthew Mitchell2, Honora Englander2,4,
Christina Nicolaidis1,5, Devan Kansagara1,3, Somnath Saha1,3 and P. Todd Korthuis1

Abstract
Background: Medically complex urban patients experiencing homelessness comprise a disproportionate number
of high-cost, high-need patients. There are few studies of interventions to improve care for these populations; their
social complexity makes them difficult to study and requires clinical and research collaboration. We present a protocol
for a trial of the streamlined unified meaningfully managed interdisciplinary team (SUMMIT) team, an ambulatory ICU
(A-ICU) intervention to improve utilization and patient experience that uses control populations to address limitations
of prior research.
Methods/design: Participants are patients at a Federally Qualified Health Center in Portland, Oregon that serves
patients experiencing homelessness or who have substance use disorders. Participants meet at least one of the
following criteria: > 1 hospitalization over past 6 months; at least one medical co-morbidity including uncontrolled
diabetes, heart failure, chronic obstructive pulmonary disease, liver disease, soft-tissue infection; and 1 mental health
diagnosis or substance use disorder. We exclude patients if they have < 6 months to live, have cognitive impairment
preventing consent, or are non-English speaking. Following consent and baseline assessment, we randomize participants to immediate SUMMIT intervention or wait-list control group. Participants receiving the SUMMIT intervention
transfer care to a clinic-based team of physician, complex care nurse, care coordinator, social worker, and pharmacist
with reduced panel size and flexible scheduling with emphasis on motivational interviewing, patient goal setting
and advanced care planning. Wait-listed participants continue usual care plus engagement with community health
worker intervention for 6 months prior to joining SUMMIT. The primary outcome is hospital utilization at 6 months;
secondary outcomes include emergency department utilization, patient activation, and patient experience measures.
We follow participants for 12 months after intervention initiation.
Discussion: The SUMMIT A-ICU is an intensive primary care intervention for high-utilizers impacted by homelessness.
Use of a wait-list control design balances community and staff stakeholder needs, who felt all participants should
have access to the intervention, while addressing research needs to include control populations. Design limitations
include prolonged follow-up period that increases risk for attrition, and conflict between practice and research;
including partner stakeholders and embedded researchers familiar with the population in study planning can mitigate these barriers.

*Correspondence: chanbri@ohsu.edu
1
Division of General Internal Medicine and Geriatrics, Oregon Health
and Science University, 3181 SW Sam Jackson Park Road L475, Portland,
OR 97239‑3098, USA
Full list of author information is available at the end of the article
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Chan et al. Addict Sci Clin Pract

(2018) 13:27

Page 2 of 11
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Introduction
A small group of high cost-high needs patients (HCHN)
accounts for a disproportionate percentage of health care
expenditures [1, 2]. These patients often have multiple
medical and psychiatric comorbidities and functional
impairments [3] that lead to costly and unnecessary care
[4], and have increased risk for adverse drug events [5].
The number of specialty physicians involved in their care
also increases risk of fragmentation of care [6], and poor
transitions of care from hospital to home [7–9]. In addition, highly prevalent adverse social factors, such as poverty, homelessness, and substance use disorders increase
the risk for overuse of hospital and emergency departments (ED), as well as underuse of primary care [10].
As healthcare systems and Accountable Care Organizations (ACOs) assume more financial risk for quality
of care delivered to patients, there are efforts to focus
and intensify resources for HCHN patients [11]. Innovative intensive primary care (IPC) programs employ
a variety of approaches to improve care quality and
reduce utilization, including use of multi-disciplinary
care teams, increased primary care access, improved
coordination and continuity of primary care, and
enhanced self-efficacy through counseling or linkages to social services/case management [2, 12]. However, there is unclear evidence for IPC effectiveness. A
recent systematic review of IPCs showed mixed effects
on utilization [13]. The only study targeting patients
with complex social needs examined the VA homeless
patient aligned care team (H-PACT) program, an intensive “ambulatory-ICU” (A-ICU) program for homeless
Veterans who were unwilling or unable to access traditional primary care [14]. While 6-months pre- and

post-enrollment analyses showed a 25% reduction
in combined hospitalization and ED utilization, the
evaluation lacked a control group. Other gaps in the
literature include few interventions targeting HCHN
patients in urban community health centers, and those
with substance use disorders and co-occurring severe
mental illness, independent risk factors for utilization
of healthcare services [15–17].
There are several reasons for this gap. These patients
are difficult to recruit in studies because of their social
complexity, and distrust of medical system and may
require partnered collaboration between researchers and community-based clinics beyond traditional
research methods [18]. Furthermore, these programs
occur in real-time in response to stakeholder and
patient needs, and evaluation plans are often lower
priority than service delivery—there are few learning
health systems that have the resources or expertise to
conduct evaluation activities in Federally Qualified
Health Center (FQHC) populations [19, 20].
We designed SUMMIT (Streamlined Unified Meaningfully Managed Interdisciplinary Team) to address
some of these gaps. We describe a practiced-based
research partnership between Old Town Clinic (OTC),
an FQHC, and Oregon Health & Science University
(OHSU), a research institution, in design of a randomized, wait-list control trial to assess whether an
A-ICU model of care compared to existing patient
centered medical home (PCMH) care improves healthcare utilization, patient experience, and self-efficacy at
6 months for medically and socially complex patients in
an urban healthcare for the homeless setting.

Fig. 1 Study timeline for SUMMIT study using “wait-list control” design. Participants are randomized to start immediately in SUMMIT or continue
“usual care” for 6 months before joining SUMMIT
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Methods/design
Study design and rationale

SUMMIT is a randomized controlled study using a
wait-list control design (see Fig. 1), described in prior
practice-based research literature [21, 22]. Patients are
randomized to start the SUMMIT intervention immediately, or continue with usual primary care for 6 months
before crossing over to the SUMMIT intervention with
data collection at multiple time-points. Thus, we address
limitations of other practiced-based evaluations of IPC
interventions that use pre-post designs without control
groups. Furthermore, compared to a randomized controlled trial, the wait-list control design is more acceptable to clinic staff, patients, and payer stakeholders who
may consider it unethical to deny patients access to the
intervention. The wait-list control design permits gradual
ramp-up of staffing.
Study setting

We recruit study participants from the OTC, an integrated medical and behavioral healthcare clinic and
FQHC in Portland, Oregon. OTC serves over 5000
patients who receive primary care services at the clinic
through four PCMH teams. The average age of OTC
patients is 48.7 years (± 12.5), and a majority are male
(60.9%), White/Non-Latino race/ethnicity (72.2%) with
very low incomes (46.5%); about one-third (30%) have
at least two chronic medical conditions. Many of OTC
patients are referred from housing programs or substance-use treatment programs—67% of OTC patients
in 2017 were homeless or unstably housed, and 61%
of patients had a substance use disorder diagnosis. In
addition to primary care, the clinic provides co-located
mental health services delivered by psychiatric nurse
practitioners; substance use counseling services and
pharmacotherapy for alcohol and opioid use disorders;
chronic disease pharmacists and an on-site pharmacy
and lab services; wellness and activity classes, including
daily acupuncture; integrated occupational and physical therapy, and social work services. Additionally, teams
have access to community health workers to assist with
patient engagement with primary care. Despite this
specialized care, a subset of OTC patients continued to
consume provider and staff attention and over utilize
hospitals and EDs. A 2014 needs assessment showed 25%
of OTC’s patients had at least one hospitalization or six
ED visits in the preceding year, and an additional 14%
had 2–5 ED visits in the preceding year, spurring development of the SUMMIT intervention.
Starting in 2006, OHSU and OTC initiated a clinical
partnership with the goal of working together to identify research opportunities in healthcare disparities,
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integrated care models and improved access for underserved populations. OHSU-affiliated providers staff OTC
clinics, supervise resident continuity clinics, and developed a social medicine curriculum for medical students.
More recently, OHSU clinician-researchers embedded at
OTC have leveraged the partnership with OTC to design
clinical innovations on hospital-based transitions of care,
and substance use treatment that utilizes the strengths of
each organization [23, 24]. These prior studies were successful in part due to intimate knowledge of the culture
of the clinic, patient populations needs, and an awareness
of the needs of the partner. Interest in a novel A-ICU
care model prompted opportunity to utilize this research
collaboration.
Eligibility criteria and recruitment

Box 1 summarizes participant inclusion and exclusion
criteria. Primary care providers (PCPs) are encouraged to
refer patients whose medical complexity, combined with
social and behavioral factors, made it difficult for existing care teams to deliver optimal care. PCPs complete a
referral form for patients that meet medical burden criteria (at least one medical condition including congestive heart failure, uncontrolled diabetes, advanced COPD
[World Health Organization group C or D], chronic kidney disease (≥ stage 3), end-stage liver disease, chronic
or severe soft tissue infections, osteomyelitis, or failure
to thrive), utilization criteria (≥ 1 hospitalization or ED
visit in the prior 6 months), and substance use disorder

Box 1 Summit A-ICU study enrollment criteria
Enrollment criteria
1 or more medical/surgical hospitalizations in last 6 months
1 or more of the following medical conditions:
  Chronic kidney disease stage III
  Congestive heart failure
  Chronic obstructive pulmonary disease, group C/D
  Diabetes with A1c > 8%
  End Stage Liver Disease (ESLD)
  Osteomyelitis/severe soft-tissue infection
Or 1 or more of the following co-morbid conditions
  Mental health
  Substance use disorder
Difficulty engaging in usual primary care (missed appointments)
Exclusion criteria
Inability to consent (as demonstrated by “teach-back” method)
Non-English speaking patients
On hospice or deemed < 6 months to live at time of enrollment
Diagnosis of terminal cancer
Inability to participate in follow up assessment due to aphasia, severe
hearing impairment or behavioral issues.
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defined by referring PCP or chart diagnosis, or behavioral health criteria (≥ 1 psychotic disorder, mood disorder,
post-traumatic stress disorder [PTSD]).
The SUMMIT team reviews referrals at regular intervals to confirm clinical appropriateness. Following
acceptance to the team, the research assistant (RA)
approaches the patient to determine study eligibility, obtain consent and complete the baseline survey.
We exclude potential participants if they are non-English speaking, are on hospice at time of enrollment
(< 6 months to live), diagnosed with terminal cancer diagnosis, are unable to consent using “teachback” method
[25], or are unable to follow-up by phone due to aphasia,
and/or severe hearing impairment at time of enrollment.
Participant sample recruitment procedures and timeline

Once consent is obtained, the RA administers the baseline survey that includes demographic, bio-psychosocial
assessments and baseline assessment of patient-reported
outcomes (Fig. 1). Following completion of the baseline survey, the participant is randomized to immediate
entrance into the SUMMIT intervention or placement
on a 6-months waitlist. Study participants receive $5 gift
cards for each completed survey.
If the participant is randomized to the wait-list control group, they remain in usual care for 6 months. After
6 months, the RA contacts the participant to repeat the
study assessments, and the participant transfers care to
the SUMMIT team. If the participant is randomized to
the intervention group, they are scheduled for an initial
intake appointment with the SUMMIT team. The RA
contacts participants at 6 and 12 months from date of
enrollment for ascertainment of outcomes with a window
of 6 weeks defined as 2 weeks prior and 4 weeks after the
due date. Participants are followed for 12 months after
SUMMIT enrollment (up to 18 months if assignment to
wait-list control group).
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We sought strategies to improve engagement with participants and minimize loss to follow up, given the complexity of the target population. We asked consented
participants to list additional phone numbers and/or
addresses as points of contact as part of baseline survey
procedures. We convened a patient advisory group, and
included in our research meetings a patient liason to
introduce the SUMMIT study to obtain feedback from
patient advocates regarding study recruitment and follow-up procedures.
Study integrity and randomization

The study design conforms to CONSORT statement
recommendations for randomized clinical trials of nonpharmacologic treatment [26]. Upon completion of consent and baseline survey, participants are randomized
to either immediate start with the SUMMIT team or be
placed on a 6-months wait-list with a 1:1 allocation per
computer-generated randomization schedule. We used
sequentially numbered, opaque, sealed envelopes to
attain allocation concealment. A member of the research
team not involved in the consent and enrollment process
generated the allocation sequence. Following allocation
of group assignment, the participant, clinic staff, and RA
conducting follow up surveys will not be blinded. The
research members conducting the statistical analysis will
be blinded from treatment assignment. We will conduct
an intent-to-treat analysis.
Ethics and dissemination

The study protocol was reviewed and approved by the
OHSU IRB in 2016 (IRB 15285). The study also received a
Certificate of Confidentiality from the National Institutes
of Health to protect data on drug and alcohol use. The protocol is registered with clinicaltrials.gov (NCT03224858).
None of the investigators have financial or competing
interests in conflict with the aims of the trial.

Box 2 Summit A-ICU intervention description and team structure
Team structure
Care coordinator—the patient’s primary point of contact, the care coordinator assists with patient follow up, acts as scribe for physician face-to-face
visits, conducts outreach activities with the goal of enhancing rapport building
Team manager—the team manager coordinates patient and team schedules, interfaces with clinic operations and administration, conducts outreach,
and leads team activities, including organizing trainings, and process improvement cycles
Physician—General internist with additional board certification in addiction who provides front line care to patients including acute and chronic
disease management, advanced care planning, medication management, and coordination of care with specialists
Social worker—a licensed clinical social worker embedded in the team who meets with the patients on Day 1 to elicit social vulnerabilities and provide counseling + case management support to patients as needed

Complex care nurse—a nurse that provides medical triage services, transitional care planning, and assists patients with health education activities as
well as outreach (accompanying patients to specialty appointments)
Pharmacist—the pharmacist works with patients and team members to assist with medication reconciliation, transitions of care, and chronic disease
medication management for patients (diabetes, heart disease) with the goal of reducing medication treatment burden
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Study arms
Intervention: SUMMIT intervention description

The intervention is a clinic team of co-located multidisciplinary staff with reduced panel size and flexible
scheduling (Box 2). Staffing consists of two half-time
physicians (1.0 FTE) with board certification in addiction medicine, one complex care nurse, two care coordinators, two licensed clinical social workers (LCSW),
pharmacist, team manager, and quality analyst. All team
members have additional training in Motivational Interviewing, patient goal setting, and palliative care principles. These didactic trainings were delivered by partner
community organizations during weekly dedicated nonclinical time built into the SUMMIT schedule. The aims
of the SUMMIT team are closely aligned with Shippe
and Montori’s theory of cumulative complexity, emphasizing ways to increase patient self-efficacy and decrease
treatment burden [27]. Core activities (Box 3) include an
initial comprehensive intake with medical and behavioral team members, patient driven health goal setting,
transitional care protocols when patients experience
hospitalizations, medication management assessment,
weekly panel review, and case management to address
social determinants of health and other unmet needs.
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The team has flexibility to conduct home visits, facilitate
unscheduled clinic visits, accompany patients to specialty
appointments, and deliver addictions treatment including medications for addiction treatment. The quality analyst assists the team in developing “Plan-Do-Study-Act”
cycles and panel management activities.
Funding SUMMIT

SUMMIT is funded through reallocation of existing staff
resources and clinical operations budget, rather than
grants. Funding for on-going operations is through a
negotiated per-member per-month payment for participants in the care model and fee-for-service payments for
patient visits with a regional Medicaid payor.
Wait‑list controls: treatment as usual

Usual care operates as a PCMH model (see Fig. 2).
Within the clinic, there are four teams consisting of
PCP, care team manager (usually a licensed practical nurse), medical assistants, and health assistants
who handle clerical and phone communication duties.
Patients have referral access to on-site non-medical
services described above, including addictions treatment, housing referrals, and behavioral health. In 2015,

Box 3 Key features and core activities of summit A-ICU
1. Transfer of care to the co-located stand-alone team Patients transfer care from existing primary care to the SUMMIT team to encourage coordinated,
unified care from a single team. Co-location offers opportunity to facilitate interdisciplinary meetings, as well as informal conversations to enact care
plans during non-visit time
2. Comprehensive initial intake The first visit(s) include a 60 min social intake with the Social worker, followed by a 60 min medical intake with provider/
care coordinator with open ended questions and focus on patient health goal elicitation and assessing self-efficacy and treatment burden. The visit
forms the basis for the patient-centered, goal-based care plan
3. Interdisciplinary team reviews Following intake, subsequent activities and appointments are determined based on patient status, medical and psychosocial complexity. Set time aside for daily huddles provide opportunity to discuss the patients scheduled for the day, and recently hospitalized or
discharged patients. Weekly “speed dating” rounds provide opportunity to review existing patients assess whether current interventions are working
and revise care plans as necessary
4. Transitions of care coordination/tracking Led by the complex care nurse, and pharmacist, the SUMMIT team developed protocols for coordination
of care for hospitalized patients to communicate pertinent information to inpatient care teams, and develop follow up care plans prior to patient
discharge
5. Built-in counseling services Led by the social worker but supported by all team members who are trained in motivational interviewing, traumainformed care, and cognitive behavioral therapy. Social workers provide individualized counseling and leverage existing linkages to mental health
prescribers as necessary
6. Navigation of social services Team members assist patients with long term care planning, advanced directives, linkages to community resources such
as disability, housing benefits
7. On-demand availability and access to off-hours warm lines A separate SUMMIT team phone number is available for patients and patient caregiver
teams to access SUMMIT team members at all hours of the day. SUMMIT physicians cover the phone during off-clinic hours to respond to patient care
needs and concerns
Additional activities/flexibility
8. Outreach visits Team members are available to conduct outreach visits for patients on an as needed basis. Visits are used as an opportunity to assess
patients outside the clinic, develop rapport and trust, and facilitate and support a health related activity (i.e. Accompaniment to specialist referrals,
delivery of medications if temporarily homebound, assistance with access to social services)
9. Pharmacy education/chronic disease medication management For select patients with non-controlled chronic disease conditions (diabetes, hypertension, heart disease), the SUMMIT pharmacist is available for 1 to 1 consultation and medication review and management. The pharmacist is empowered to enact the care plan and titration or tapering of medications
10. In-visit scribing Care coordinators sit in on medical visits with provider and patients and scribe for the provider. This activity promotes unified communication of the care plan between patient, care coordinator, and physician; and allows improved patient experience during face-to-face visits

Chan et al. Addict Sci Clin Pract

(2018) 13:27

Page 6 of 11

Fig. 2 Comparison of “usual care” team (left) and SUMMIT A-ICU (right)

OTC introduced embedded CHW workers in partnership with a regional Medicaid payor [2]. The CHWs
have training in addictions or mental health counseling
and engage HCHN patients outside the clinic setting.
Activities of the CHW include motivational interviewing, case management, advocacy, facilitation of multidisciplinary care planning, collaboration with primary
care, and individual resource building for short-term
(< 6 months) engagement.

Measurement
Data collection

The RA administers baseline and follow up surveys to
participants using paper questionnaires and then enters
responses into a REDCap database designed with
branching logic, range checks, and forced functions to
increase data quality. The RA is independent from the
clinical teams to decrease risk of social desirability bias
in survey response. The RA stores paper questionnaires
in a locked file cabinet on site in case of discrepancies
in the REDCap database. We use administrative data to
examine care utilization outcomes. If a participant is
lost to follow up or does not engage with the care team,
we will still be able to obtain inpatient and outpatient
utilization data.

Outcomes
Primary outcome

The primary outcome is total inpatient hospitalizations
at 6 and 12 months after study enrollment as assessed by
PreManage, a consortium of local state and cross-state
hospitals that sends in real-time hospital administrative
event information (inpatient admissions and discharges,
ED visits) to health plans and provider groups.
Secondary outcomes

The secondary outcomes are ED utilization at 6 and
12 months after study enrollment, and patient reported
activation at 6 and 12 months of the intervention. We
assess patient activation using the Patient Activation
Measure (PAM-13) [28, 29], a validated tool used widely
in research to assist in tailoring care plans, and evaluation assessment.
Exploratory outcomes

We will also consider pre-specified, exploratory outcomes (Table 1). We will use PreManage to calculate
average length of stay per inpatient hospitalization;
mortality (based on chart record review); outpatient
clinic visits; and housing status (assessed using a selfreported survey question: “Which of the following best
describes your current residence?”) at 6 and 12 months.
We assess patient experience of healthcare at 6 and
12 months using the Consumer Assessment Healthcare Professionals (CAHPS); [30] we also assess patient
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Table 1 Participant timeline and assessments (per SPIRIT guidelines) [50]
Timepoint*

Study period
Enrollment/
allocation

Post-allocation

Close–out

− t1 = 0

6 months

12 months

X

X

18 months

18 months

Enrollment
Eligibility screen

X

Informed consent

X

Baseline 1

X

Allocation

X

Interventions
Immediate
Wait-list

X

X

X

X

X

X

X

X

X

X

Assessments
Baseline 1 and 2
“Please choose the number that best describes how you
feel?” (0–10) [32]

X

PHQ-9 [38]

X

AUDIT 10 [40]

X

Self reported alcohol use disorder history

X

DAST [40]

X

Self report substance use disorder history

X

Tobacco use

X

Self reported falls over 6 months

X

Telephone interview for cognitive status (TICS14) [51]

X

Health Literacy 3 item questionnaire [36]

X

ESSI 7 social support questionnaire [20]

X

Food security 2 [3, 7]

X

Income source

X

Education

X

Race-ethnicity

X

Housing status

X

Outcomes
ED visits 6 months prior

X

X

X

X

X

Hospitalizations 6 months prior

X

X

X

X

X

PAM-13 [29]

X

X

X

X

X

CAHPS-10 [52]

X

X

X

X

X

SF-12v2 [31]

X

X

X

X

X

Chaos Scale 6 [33]

X

X

X

X

X

Mortality/death

X

X

X

X

X

PHQ patient health questionnaire, AUDIT alcohol use disorder identification test, DAST drug abuse screening test, TICS telephone interview for cognitive status, ESSI
Enriched social support instrument, ED emergency department, PAM patient activation measure, CAHPS consumer assessment of healthcare providers and systems,
SF-12 short form health survey

reported quality of life using the SF-12 survey [31], a
single item palliative care measure (Edmonton Symptom Assessment System (ESAS) [32], and a six-item life
chaos measure by Wong that assessed self-reported ratings of participants’ routines and daily activities [33].
We will assess the impact of SUMMIT on all OTC clinical staff by assessing a two-item burnout measure periodically during implementation [34].

Socio‑demographic and other potential covariates

Self-reported socio-demographic variables include age,
gender, race/ethnicity, marital status, educational attainment, and annual household income. Part of the motivation for this study is to learn more about these patients
and determine how psychosocial factors, of which little
are captured in health records or administrative data,
play a role in their healthcare experiences. Therefore, we
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also assessed perceived social support [35], current living situation, self-reported health literacy [36], and food
insecurity [37]. We also screen for depression using the
patient health questionnaire (PHQ-9) [38], cognitive
impairment using telephone interview for cognitive status (TICS) [39], and drug and alcohol use disorders using
the drug abuse screening test (DAST) and the alcohol use
disorder identification test (AUDIT) [40]. Measures were
proposed during planning meetings, and pilot tested
prior to finalizing.
Sample size calculations

We conducted several sample size calculations to estimate the study size population.
We examined the sample size necessary to demonstrate
a 40% reduction in our primary outcomes of hospital utilization over 6 months. We determined average number
of hospitalizations over the prior 6 months for a pilot
sample of SUMMIT patients (2.3 hospitalizations/person over 6 months, SD = 1.9). Assuming 80% power and
2-tailed alpha, the sample size estimated was 140 participants. Based on preliminary data, we believed 400 existing patients met SUMMIT eligibility for utilization, but
targeted an enrollment of 200 based on potential difficulties with recruitment and retention. We used prior literature to determine an effect size of a four-point increase
on the secondary outcome of PAM score, with standard deviation of 10; therefore, at 80% power and 2 tailed
alpha, the sample size estimated was 196 [41].
Statistical analyses

We will use descriptive statistics to describe the study
population and assess similarity of baseline characteristics between study arms using Chi square, t-tests, and
Fisher’s exact test. For each outcome, we will conduct
intent-to-treat analyses using difference-in-differences
regression to compare the study arms during baseline
and 6-months and 12-months follow up [42]. Use of a
wait-list control design permits two methodologies to
assess outcome changes. The first analysis will be a comparison of intervention and control group outcomes at
6-months, adjusting for any baseline covariates that differ by chance in each group. The second analysis will
use the wait-list control to conduct a repeated measures
analysis controlling for calendar time to account for secular changes in the intervention and enhanced usual care
groups over time. We also plan to conduct pre-specified
sub-group analyses to identify which SUMMIT patients
benefit most from the intervention as currently constructed, including: study participants with only medical
complexity; participants with active/primary substance
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use disorders; and participants who have housing instability at enrollment. Though these subgroup analyses will
likely be underpowered, they may inform refined referral
criteria or assist in a refined intervention.
Qualitative and formative evaluation

In addition to the primary evaluation, we are conducting qualitative interviews with clinical staff members
and patient participants to explore how the intervention
evolves over time and gain insights for what intervention
activities worked well and what can be improved. We are
conducting formative evaluation through quantitative
and qualitative methods to describe intervention components, assess fidelity, and develop lessons learned [43].
This includes tracking number of visits to medical, mental health, pharmacy, nursing providers, tracking whether
patients received SUMMIT core activities, and documenting issues affecting implementation of the program
as intended.
Data monitoring

The research team will produce administrative reports
on a quarterly basis that describe study progress including: accrual, demographic, study subjects status, outstanding REDCap study forms, error rate pertaining to
adherence to inclusion/exclusion criteria and the study
protocol. These reports will be reviewed internally for
ongoing quality control and submitted at the request of
the IRB.

Discussion
This paper describes a partnered approach to design
and evaluation of a novel intensive A-ICU model of primary care for medically and socially complex patients at
an FQHC clinic primarily serving low-income patients
experiencing homelessness or substance use disorders.
The results of this study will contribute to an evolving
literature on intensive primary care interventions that
addresses two gaps: (1) a need for more practiced-based
research studies that include control populations; and (2)
a focus on HCHN patients with high rates of homelessness and substance use.
While there is interest in improving quality of care
and lowering costs for HCHN patients, how to achieve
this is unclear. Intensive primary care interventions are
an approach popularized by Camden Coalition’s “Hotspotters” [44] and others like it; however, there are few
published evaluations to support investing resources
into these models. There are several reasons why these
studies do not get published. Many of these intervention
programs lack resources or expertise to conduct formal
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evaluations and dissemination activities—often, programs are implemented, and community partners move
on to the next pressing need. Another reason is that
multi-component interventions like those for HCHN
patients are difficult to describe and vary depending
on local context [13, 45]. Patients affected by poverty,
homelessness, and substance use are understudied, and
have stigma associated with research participation that
makes traditional clinical trial participation challenging. Our study protocol addresses these limitations by
using a community-partnered approach and embedded
researchers that meets both programmatic and research
needs.
The wait-list randomized control design of the SUMMIT evaluation offers a balance between research and
practice priorities. From a research perspective, incorporating randomization to a control group allows the
study to address potential bias resulting from regression
to the mean, and minimizes confounding that is present
in pre-post designs. From a programmatic perspective,
the wait-list control design meets the needs of clinical
priorities in that all participants who are accepted have
the opportunity to receive the intervention, and allow for
gradual scaling up of the intervention over time to meet
staff capacity [46, 47]. If the trial is successful, this study
design may serve as a model for future evaluations of
multi-component, interdisciplinary, practice-based evaluations of interventions for HCHN populations in other
settings.
Use of this design is not without trade-offs, including accounting for extended follow-up time that may
increase risk for attrition [22]. We limited the waitlist to 6 months and ask for multiple sources of contact information from participants at baseline to help
decrease this risk; however, assessing primary and
secondary outcomes at 6 months may be too short a
time period to detect noticeable differences in utilization and self-efficacy because behavior change interventions often take up-front investments and require
extended time horizons (i.e. multiple years) to demonstrate efficacy [48, 49]. Implementing practice-based
research often leads to conflicts between research and
practice, and our experience has been no exception;
however, use of embedded researchers familiar with
the patient population and clinic culture, and incorporating input from stakeholders was beneficial for evaluation planning.
In conclusion, we are testing a novel model of primary
care using multi-disciplinary teams with reduced panel
size and increased flexibility as an intervention to improve
quality of care for patients with multiple chronic medical and social complexity. The outcomes of the SUMMIT
study will provide real-world evidence about the efficacy of
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an A-ICU model of care for HCHN patients particularly
sensitive to social determinants of health.
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